Emphasis on Product [Vision Care (Spectacles, Contact Lens), Surgery Devices (Cataract, Glaucoma, Refractive, Vitreoretinal, and Other Surgery Devices), Diagnostic and Monitoring Devices (Optical Coherence Tomography Scanner, Fundus Camera, Tonometer, Perimeter, Optical Biometry, Ophthalmic Operating Microscopes, Slit Lamp, Autorefractors, Other Diagnostics & Monitoring Devices), Disease Area (Cataract, Glaucoma, Age Related Macular Diseases, Diabetic Retinopathy, Others), End Users (Hospitals, Ophthalmic Clinics, Ambulatory Surgery Centers, Optical Centers) and Region/Country
Ophthalmic Devices derived revenue of US$ 31,856.4 million in 2019 and are expected to fetch US$ 46,337.4 million by 2026 displaying significant CAGR of 5.2% over the forecast period (2021-2026). With the introduction of the ophthalmic devices incorporating these sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye-related disorders. A growing number of people are receiving ophthalmic prostheses due to the aging population and the increasing prevalence of ophthalmic conditions. Of those with visual impairment or blindness, the five major eye conditions such as cataract, macular degeneration, glaucoma, diabetic eye disease, and refractive error account for approximately three-quarters of all cases. In recent years, the growing disposable income has encouraged people to buy quality eyewear products that are in perfect amalgamation with their increasing living standards. Moreover, people are now opting for trendy and designer sunglasses according to the latest trends prevailing in the market.
Population aging is one of the major factors that is responsible for the increase in the incidence and prevalence of patients suffering from eye defects. Statistics reveal that 65% of those with visual impairment and 82% of those who are blind are over 50 years old. As per the United Nations, Population aging refers to the change in the composition of a population such that there is an increase in the proportion of older persons. Growth in certain regions and countries is decelerating whereas population aging is accelerating. As per WHO lifestyle changes and urbanization – will also dramatically increase the number of people with eye conditions, vision impairment, and blindness in the coming decades. Myopia is one such condition which is a major public health concern in several East Asian countries, where the condition affects 80% to 90% of high school graduates. Ophthalmology and its subspecialties have been at the forefront of medical innovation and have embraced the rapid advances in several technologies, including pharmacology, imaging, data processing, and devices. Technological innovations in ophthalmology provide ophthalmologists with new ways to improve the quality of care. Scientific and technological advances have also opened a wide range of clinical and research opportunities in the field of eye care.
Population Affected with Vision Impairment
Essilor International S.A., Bausch Health Companies, Ellex Medical Lasers, Second Sight Medical Products, Hoya Corporation, Alcon, Johnson & Johnson, Carl Zeiss Meditec AG, Escalon Medical Corp., Topcon Corporation, Nidek Co., Staar Surgical, Lumenis, Glaukos Corporation, and Vision Care are some of the prominent players operating in the global ophthalmic devices market. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products.
Insights Presented in the Report
“Amongst product type, vision care devices segment holds the major share”
Based on product type, the market is fragmented into vision care devices, surgery devices, and diagnostic and monitoring. The vision care devices dominated the market with a share of 79.2% in 2019 and are expected to maintain their dominance during the forecast period owing to the increasing usage of electronic devices such as mobiles, PCs, and laptops which results in various eye-related defects.
“Amongst vision care products, spectacles sub-segment dominated the market in 2019”
The vision care segment is further subdivided into spectacles and contact lenses. Spectacles dominated the market with a share of 81.6% in 2019 and are expected to maintain its dominance during the forecast period owing to the increasing age, which is probably due to the increased need for presbyopic and post-cataract surgery refractive correction. The current use of spectacles also increased with increasing socioeconomic status possibly related to the increased level of education. However, the contact lenses segment is anticipated to witness the highest CAGR during the forecast period (2021-2026).
“Amongst surgery devices segment, cataract surgery devices segment is expected to dominate the market during the analyzed period”
Based on the surgery devices, the market is bifurcated into cataract surgery devices, glaucoma surgery devices, refractive surgery devices, vitreoretinal surgery devices, and other surgery devices. The cataract surgery devices dominated the market with a share of 66.8% in 2019 and are expected to maintain its dominance during the forecast period owing to the most frequent surgical procedure being performed in many developed countries, providing significant, long-term, and cost-effective improvements in the quality of life for patients of all ages. However, glaucoma surgery devices are anticipated to witness the highest CAGR during the analyzed period.
“Amongst ophthalmic diagnostic and monitoring devices type, optical coherence tomography/scanning laser ophthalmoscopy dominated the market in 2019”
Based on the ophthalmic diagnostic and monitoring devices type, the market is segmented into optical coherence tomography/scanning laser ophthalmoscopy, fundus camera, tonometer, perimeter, optical biometry, ophthalmic operating microscopes, slit lamp, autorefractors, and other diagnostic and monitoring devices. In 2019, optical coherence tomography/scanning laser ophthalmoscopy accounted for 18% of market revenue share and dominated the market. The segment is most commonly utilized in the clinic to diagnose retinal diseases. OCT has become essential in ophthalmology, offering a superior resolution of the retina and some of the adjacent tissues for diagnosis and treatment of eye diseases. New OCT modalities have now been assimilated into ophthalmic oncology to help track the status of ocular and periocular tumors through retinal symptoms.
“Amongst disease area, cataract is expected to dominate the market during the analyzed period”
Based on the disease area, the market is fragmented into a cataract, glaucoma, age-related macular degeneration, diabetic retinopathy, and others. In 2019, the cataract accounted for the maximum market share with 28.5% and is expected to be the leading segment of the ophthalmic devices market during the forecast period. According to the latest assessment by WHO, cataract is responsible for approximately 51% of world blindness, which represents about 20 million people. Although cataracts can be surgically removed, barriers exist in many countries that prevent patients to access surgery. However, Diabetic retinopathy is expected to witness the highest CAGR growth during the forecast period 2021-2026.
“Amongst end-users, optical centers dominated the market in 2019”
Based on end-users, the ophthalmic devices market is fragmented optical centers, hospitals, ophthalmic clinics, and ambulatory surgery centers. In 2019, optical centers accounted for 47.2% of market revenue share and dominated the market. However, the ophthalmic clinic segment is anticipated to witness the highest CAGR during the forecast period.
“North America represents one of the largest markets of ophthalmic devices market”
For a better understanding of the market dynamics of the ophthalmic devices market, a detailed analysis was conducted for different regions across the globe including North America (US, Canada, and Rest of North America), Europe (Germany, UK, France, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), and Rest of the World has been conducted. North America dominated the market and generated revenue of US$ 10,826.2 million in 2019 owing to the rising prevalence of ocular disorders, growth in the geriatric population, increase in healthcare expenditure, and technological advancements in ophthalmic devices. Approximately 11 million Americans aged 12 years and older could improve their vision through proper refractive correction.
Reasons to buy this report:
Customization Options:
The Ophthalmic Devices Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Industry Performance
4. Executive Summary
5. Current And Projected Scenario Of The World's Eyesight
6. Covid-19 Impact On Ophthalmic Services
7. Market Overview
8. Reimbursement Policy
9. Legal & Regulatory Framework
10. Demand And Supply Side Analysis
11. Value Chain Analysis
12. Market Insights By Product
13. Ophthalmic Devices Market Insights, By Disease Area
14. Ophthalmic Devices Market Insights, By End Users
15. Market Insights By Region
16. 16 Competitive Scenario
17. Top Company Profiles
Analyzing the historical market, estimation of the current market, and forecasting the future market of the Global Ophthalmic Devices Market were the three major steps undertaken to create and analyze the adoption of Ophthalmic Devices across various industry verticals in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the ophthalmic devices sector. Post assumption and validation of market numbers through primary interviews, we employed a top-down approach to forecast the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the Ophthalmic Devices through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the Ophthalmic Devices market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments included in the report as the product, disease area, and end-user. Further country-level analyses were conducted to evaluate the overall adoption of the ophthalmic devices in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of Ophthalmic Devices. Further, we conducted factor analysis using dependent and independent variables such as the growth of the growing prevalence of eye disorders and the accelerating geriatric population. A thorough analysis was conducted for demand and supply-side scenario considering top partnerships, merger and acquisition, business expansion, and product launches in the Ophthalmic Devices industry across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the Ophthalmic Devices market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e. top-down approach was applied to arrive at the market forecast about 2026 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the ophthalmic devices market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of product, disease area, and end-users of the ophthalmic devices market.
The main objective of the Ophthalmic Devices Market Study
The current & future market trends of Ophthalmic Devices were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends were determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
